Start Schlagworte Produktstart

Schlagwort: Produktstart

Formycon verringert Verluste

PLATTFORM LIFE SCIENCES Stefan Riedel -
Die Aktie des Biosimilarspezialisten Formycon (ISIN: DE000A1EWVY8) startet den Börsentag nach der Bilanzpressekonferenz zu den Geschäftszahlen für 2025 mit deutlichen Kursgewinnen. Das Unternehmen hat...
Symbilbild "Surging drug approvals" (Health and nutrition concept. Indoor image young female holding food supplement bottle sitting with laptop surfing searching internet for online review of food supplements products on internet.) Copyright: Praewphan - stock.adobe.com

Surging expected growth of drug approvals over the next decade

Bioscience Valuation BSV Phillip S. Steinbach, Qianyu Gu und Dr med. Kerstin M. Bode-Greuel -
In March 2024, we reported a gradual increase of new drug approvals over the past 30 years, combined with an increasing focus on cancer,...